Curettage and Electrodessication

On this page

Curettage & Electrodessication - Scoop & Sizzle

  • A destructive technique: curettage ("scoop") removes friable tissue; electrodessication ("sizzle") for hemostasis & residual cell destruction.
  • Indications: Superficial Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC) in situ (Bowen's disease), seborrheic keratoses, viral warts, pyogenic granulomas.
  • Procedure:
    • Local anesthesia administered.
    • Curette scrapes tumor until firm, normal dermis is felt.
    • Electrodessication applied to the base & margins.
    • Typically 2-3 cycles performed for optimal results.

    ⭐ C&E relies on the textural difference between friable tumor tissue and firm normal dermis for selective removal.

  • Advantages: Rapid, office-based procedure, cost-effective.
  • Disadvantages: Operator-dependent, potential for scarring, no histological margin control. Curettage and Electrodessication Steps

Curettage & Electrodessication - The Zap Kit

  • Instruments: Dermal curette (various sizes), Hyfrecator (electrosurgical unit).
  • Principle: Physical removal by scraping (curettage) followed by electrical desiccation of the lesion base and margins.
  • Indications: Benign (seborrheic keratoses, warts, pyogenic granulomas), Pre-malignant (actinic keratoses), Malignant (superficial basal cell carcinoma, SCC in situ).
  • Technique: Anesthetize → Curette lesion → Electrodessicate base & margins → Repeat 2-3 cycles.
  • Advantages: Quick, cost-effective, good hemostasis.
  • Limitations: Scarring risk, no specimen for complete margin histology.

⭐ Hyfrecators used in electrodessication deliver high-frequency, low-voltage current for coagulation and desiccation, typically in repeated cycles with curettage.

Curettage & Electrodessication - When to Scrape

Curettage and Electrodessication Steps

Indications for Curettage & Electrodessication (C&E): A targeted approach for superficial skin lesions. Not for lesions with deep dermal invasion or high-risk features.

  • Benign Lesions:
    • Seborrheic keratoses
    • Verrucae (warts)
    • Molluscum contagiosum
    • Pyogenic granulomas
    • Acrochordons (skin tags)
  • Pre-Malignant Lesions:
    • Actinic keratoses (especially hypertrophic/resistant)
  • Malignant Lesions (Low-Risk, Well-Defined):
    • Superficial Basal Cell Carcinoma (BCC)
    • Squamous Cell Carcinoma (SCC) in situ (Bowen's disease)
    • Keratoacanthoma (select cases, e.g., small, non-aggressive)

⭐ For superficial Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) in situ (Bowen's disease), C&E is often performed in 2-3 cycles for optimal clearance.

Curettage & Electrodessication - Good & Gnarly

  • Good:
    • Rapid, simple, inexpensive.
    • Achieves good hemostasis.
    • Indications: Benign lesions (e.g., warts, seborrheic keratoses, molluscum contagiosum), superficial BCC/SCC in situ.
  • Gnarly:
    • Potential for scarring, hypopigmentation.
    • 'Blind' technique: no histological margin control.
    • Higher recurrence for aggressive or deep tumors.
    • Avoid in high-risk anatomical sites.

⭐ While C&E is quick and cost-effective, it is a 'blind' procedure with no histological margin control, leading to higher recurrence rates for certain aggressive tumors compared to Mohs surgery or excision.

Curettage & Electrodessication - Red Flags & Recovery

  • Contraindications:
    • ⚠️ Absolute: Suspected melanoma.
    • Lesions needing precise histology (morpheaform BCC, recurrent tumors, H-zone lesions).
    • Patients with pacemakers/ICDs (use bipolar cautery).
    • Significant bleeding disorders.
  • Potential Complications:
    • Scarring (keloids, hypertrophic).
    • Pigmentary changes (hypo/hyper).
    • Infection, bleeding, pain.
    • Recurrence.
  • Recovery & Wound Care:
    • Keep clean, apply ointment, dress.
    • Gentle cleansing after 24-48 hrs.
    • Sun protection vital.
    • Healing: 2-4 weeks. Curettage and electrodessication procedure

⭐ C&E is contraindicated for suspected melanoma and lesions requiring precise histological margin assessment, such as morpheaform BCC, recurrent tumors, or lesions in high-risk areas (e.g., 'H-zone' of the face).

High‑Yield Points - ⚡ Biggest Takeaways

  • C&E is primarily used for superficial, non-aggressive skin cancers like nodular Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) in situ.
  • The procedure involves mechanical scraping with a curette followed by electrodessication for hemostasis and destruction of residual tumor cells.
  • Typically performed in 2-3 cycles to ensure thorough tumor removal and achieve high cure rates.
  • High cure rates (often >90%) are achievable for appropriately selected, low-risk lesions.
  • Contraindicated for aggressive BCC subtypes (e.g., morpheaform), recurrent tumors, or lesions in anatomically challenging or cosmetically sensitive areas.
  • Key advantages include speed, cost-effectiveness, and simplicity; a common disadvantage is scarring and hypopigmentation.
  • It is not ideal for lesions requiring precise margin control or those with deep dermal invasion.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Curettage and Electrodessication

Test your understanding with these related questions

Sun damage causes malignant transformation of the skin by:

1 of 5

Flashcards: Curettage and Electrodessication

1/10

Augmented TCA (TCA 35% plus Jessner s solution or glycolic acid 70%) is an example of _____ chemical peel

TAP TO REVEAL ANSWER

Augmented TCA (TCA 35% plus Jessner s solution or glycolic acid 70%) is an example of _____ chemical peel

Medium (papillary dermal)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free
Curettage and Electrodessication - Free Indian Medical PG